Apraclonidine 0.5% Versus 1% for Controlling Intraocular Pressure Elevation After Argon Laser Trabeculoplasty
| Autor: | M. Bruce Shields, Alfred A Assalian, R. Rand Allingham, Anisa B. Threlkeld |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
Laser surgery
Intraocular pressure Trabeculoplasty genetic structures business.industry medicine.medical_treatment Eye disease Significant difference Argon laser trabeculoplasty medicine.disease eye diseases Apraclonidine Hydrochloride Anesthesia medicine sense organs Apraclonidine business medicine.drug |
| Zdroj: | Ophthalmic Surgery, Lasers and Imaging Retina. 27:657-660 |
| ISSN: | 2325-8179 2325-8160 |
| DOI: | 10.3928/1542-8877-19960801-03 |
| Popis: | * BACKGROUND AND OBJECTIVE: Topical apraclonidine hydrochloride 1% is effective for controlling the intraocular pressure (IOP) rise following argon laser trabeculoplasty (ALT). The 0.5% formulation has recently become available commercially. The objective of this study was to compare the efficacy of these two concentrations for controlling IOP after ALT. * PATIENTS AND METHODS: All patients undergoing ALT were prospectively randomized to receive either 1% or 0.5% apraclonidine 1 hour before and immediately after the laser surgery. IOP was measured before and 2 and 24 hours after the treatment. * RESULTS: No statistically significant difference in mean IOPs was found between the two treatment groups at any time. * CONCLUSION: These data suggest that 0.5% and 1% apraclonidine are equally effective for preventing IOP rise after ALT. [Ophthalmic Surg Lasers 1996;27:657-660.] |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|